纳米姜黄素作为营养策略对囊性纤维化患儿临床与炎症因子的影响:随机对照试验研究方案
该研究为前瞻性双盲对照试验,在伊朗马什哈德Akbar儿童医院纳入囊性纤维化患儿,比较纳米姜黄素(按体表面积最大剂量80 mg)与安慰剂干预3个月的效果。主要结局为血清IL-6、IL-10、hs-CRP、粪便钙卫蛋白及鼻咽拭子中性粒细胞计数等炎症指标,次要结局包括肺功能、人体测量和生活质量。
要点
- 纳米姜黄素按体表面积给药,最大剂量80 mg,干预3个月。
- 主要结局为血清IL-6、IL-10、hs-CRP、粪便钙卫蛋白及鼻咽拭子中性粒细胞。
- 次要结局包括肺功能、人体测量和生活质量,干预前后各评估一次。
核心结论
- 由于姜黄素对囊性纤维化疾病有多方面作用,可能作为囊性纤维化治疗中的营养策略。
研究设计与样本
- 前瞻性、双盲、安慰剂对照随机对照试验,在伊朗马什哈德Akbar儿童医院开展。
- 纳入符合入排标准的囊性纤维化患儿,纳米姜黄素按体表面积给药、最大剂量80 mg,安慰剂对照,干预3个月。
主要发现
- 主要结局为基于血清IL-6、IL-10、hs-CRP、粪便钙卫蛋白及鼻咽拭子中性粒细胞计数评估炎症。
- 次要结局为通过肺量计、人体测量和生活质量进行临床评估。
- 上述指标在干预前和3个月后各评估一次。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Cystic fibrosis (CF) is a genetic disorder, which is caused by the CFTR protein defects. Along with CFTR dysfunction, inflammation plays a key role in the disease outcomes. Inflammation may develop due to the internal dysfunction of the CFTR protein or external factors. Curcumin affects the CFTR protein function primarily as a corrector and potentiator and secondary as an anti-inflammatory and antimicrobial agent. The present study aims to assess the impact of nano-curcumin on clinical and inflammatory markers in children with CF. METHODS: This prospective, double blind control trial will be conducted at the Akbar Children's Hospital in Mashhad, Iran. Children with CF will be enrolled based on the eligibility criteria. Placebo and curcumin with the maximum dose of 80 mg considering the body surface of the patients will be administrated for 3 months. The primary outcome is to evaluate inflammation based on serum interleukin-6, interleukin-10, and hs-CRP, stool calprotectin, and neutrophil count of nasopharyngeal swab. The secondary outcome involved clinical assessment via spirometry, anthropometrics, and quality of life. They will be assessed before and after 3 months. DISCUSSION: Due to the multifarious effects of curcumin on CF disease, it could be proposed as a nutritional strategy in the treatment of cystic fibrosis. TRIAL REGISTRATION: Iranian Registry of Clinical Trials IRCT20200705048018N1 . Registered on July 10, 2020.
引用
- Talebi S, Safarian M, Jaafari MR, et al. The effects of nano-curcumin as a nutritional strategy on clinical and inflammatory factors in children with cystic fibrosis: the study protocol for a randomized controlled trial. Trials. 2021. PMID: 33879218. doi:10.1186/s13063-021-05224-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。